←
Knight Genetics257 posts
Knight Genetics avatar

Knight Genetics

@KnightGenetics

Official account of Prof. Julian Knight's lab at @NDMOxford @OxfordMedSci and @HumanGeneticsOx Using functional genomics to understand the human immune system

◷ Joined February 2016▧ 44 Photos and videos
Knight Genetics avatar
Knight Genetics@KnightGenetics·Mar 2

Our new study shows a genetic variant fine-tunes MTOR and immune crosstalk, improving survival in pneumonia-associated #sepsis - toward personalised treatments. Congrats to @pingzhangneho and everyone involved! @HumanGeneticsOx @CAMS_COI_Ox @NatureComms nature.com/articles/s41467-0…

Ping Zhang avatar
⟳ Knight Genetics retweeted
Ping Zhang@pingzhangneho·Feb 27

Glad to share our study showing how a common genetic variant impacts immune cell-cell communication and patient survival in pneumonia-associated sepsis, providing a framework for stratified therapy. Thanks to our funders and everyone involved. nature.com/articles/s41467-0…

Post attachment
Cell Genomics avatar
⟳ Knight Genetics retweeted
Cell Genomics@CellGenomics·24 Apr 2023

Comprehensive epigenomic profiling reveals the extent of disease-specific chromatin states and informs target discovery in ankylosing spondylitis dlvr.it/Sn0DBD

Knight Genetics avatar
Knight Genetics@KnightGenetics·27 Apr 2023

Our research on the chromatin landscape of ankylosing spondylitis (AS) has just been published in @CellGenomics. An important step towards future drug discovery. Congratulations to @DrCarlaCohen, @HumanGeneticsOx, and and everyone involved!

Really excited to present our research on epigenomics of #AnkylosingSpondylitis, a spinal arthritis. Published this week in @CellGenomics: doi.org/10.1016/j.xgen.2023.… 1st authors: Andrew Brown, Ola Mielczarek, Gabriele Migliorini and @DrCarlaCohen A 🧵

Post attachment
Knight Genetics avatar
Knight Genetics@KnightGenetics·26 Apr 2023

We are excited to share our recent work mapping the host response to sepsis at single-cell resolution. The study, led by @andrewjkwok and published in @NatImmunol, identifies a subset of immature neutrophils which is increased in severe sepsis. Big thanks to everyone involved!

Julian Knight and colleagues find that altered granulopoiesis and increases in immature immunosuppressive neutrophil subsets are associated with poor outcomes in some patients with sepsis. Read it here: rdcu.be/daDeU nature.com/articles/s41590-0…

Carla Cohen avatar
⟳ Knight Genetics retweeted
Carla Cohen@DrCarlaCohen·25 Apr 2023

Our study on AS epigenomics has been covered by @GenomeWeb Watch this space for link to paper and 🧵

Ankylosing Spondylitis Genomics Study Points to Genes, Pathways for Drug Discovery. Researchers analyzed transcriptomic and epigenomic features in immune cells from cases and controls alongside genetic risk data. ow.ly/Mxen104EMMw

Knight Genetics avatar
Knight Genetics@KnightGenetics·3 Nov 2022

For more information, you can refer to our full publication and the associated R package: R package: https://t.co/S1ozgqSsI8 Publication: https://t.co/iFI7bawSQh (14/15)

Knight Genetics avatar
Knight Genetics@KnightGenetics·3 Nov 2022

In summary, we derived a transcriptional measure of risk (SRSq) which captures information on a patient's overall immune function. SRSq can be predicted using SepstratifieR and is associated with illness severity in adult and paediatric sepsis, influenza, and COVID-19. (13/15)

Post attachment
Knight Genetics avatar
Knight Genetics@KnightGenetics·3 Nov 2022

In contrast to our observations in sepsis, mediation analysis revealed that in COVID-19 SRSq likely increases risk of death mostly via alterations to lung function. Thus, single-organ dysfunction is a much more important mediator of death in COVID-19 than in sepsis. (12/15)

Post attachment
Knight Genetics avatar
Knight Genetics@KnightGenetics·3 Nov 2022

SRSq was also predictive of severity in a cohort of COVID-19 patients (COMBAT study). SRSq estimates correlated not only with patient groupings proposed by the WHO, but also with neutrophil counts, clinical measures of severity (e.g. SOFA and P/F ratio), and mortality. (11/15)

Post attachment
Knight Genetics avatar
Knight Genetics@KnightGenetics·3 Nov 2022

To assess its applicability, we tested SepstratifieR in patients who would not fulfil conventional sepsis criteria. SRSq was detectable in patients hospitalised with H1N1 influenza (MOSAIC study). Moreover, SRSq correlated with the degree of oxygen supplementation (10/15).

Post attachment
Knight Genetics avatar
Knight Genetics@KnightGenetics·3 Nov 2022

We confirmed that SepstratifieR is applicable in both adult and paediatric sepsis. In paediatric patients, higher SRSq scores were associated with higher illness severity. Moreover, the gene expression program captured by SRSq was present in both patient populations. (9/15)

Post attachment
Knight Genetics avatar
Knight Genetics@KnightGenetics·3 Nov 2022

We created an algorithm to predict SRS and SRSq in new cohorts: SepstratifieR. We trained random forest models for prediction and borrowed a method for batch alignment developed for single-cell omics. SepstratifieR is publicly available: https://t.co/S1ozgqRUSA (8/15)

Post attachment